Profil

Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Staff turnover in EUR2 516 6323 276 4507 337 09020 645 404744 831
Staff turnover in EUR2 516 6323 276 4507 337 09020 645 404744 831
Akcie denominované v EUR20212022202320242025
Počet vydaných akcií (v milionech)3,283,663,6839,412,56
Dividenda na akcii-----
Zisk na akcii bez emise nových akcií-0,23-0,43-0,38-0,120,06
Přehled zisků a ztrát v milionech EUR dle IAS/IFRS20212022202320242025
Obrat13,818,033,675,6121,3
Provozní zisk (EBIT)-9,6-14,7-14,4-3,54,9
Zisk před zdaněním (EBT)-9,6-16,0-13,3-3,34,2
Annual net profit/ loss-7,5-14,6-13,7-3,72,0
Rozvaha v milionech EUR IAS/IFRS20212022202320242025
Aktiva
Celková běžná aktiva32,931,427,244,865,5
Celková fixní aktiva63,456,648,743,541,7
Celková aktiva96,388,075,988,3107,2
Závazky
Celkové krátkodobé závazky11,312,613,220,933,4
Celkové dlouhodobé závazky8,16,66,08,66,9
Oprávky celkem0,40,00,00,10,0
Základní kapitál77,068,956,758,766,9
Celkové závazky96,388,075,988,3107,2
Management:
Chris Fair
Florence Barrère de Groot
Katherine Sage
Philippe Saudan
Joost de Bruijn
Daniel Geiger
G. Joseph Ross
John Griffin
Laura Rosa
Marcel Borger
Sjoerd Musters
Představenstvo:
Joost de Bruijn
Kimberley Elting
Oliver Walker
Clemens van Blitterswijk
Struktura akcionářů v %:
BlackRock Fund Advisors 0,98
BlackRock Investment Management (UK) Ltd. 1,80
C A C M Oomen 24,74
Deka Investment GmbH 1,88
Janus Henderson Investors UK Ltd. 1,16
Joh. Berenberg, Gossler & Co. KG (Investment Management) 2,25
Pegasus Global Opportunity Fund Ltd. 2,70
UBS Asset Management Switzerland AG 2,69
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2,97
Zürcher Kantonalbank (Investment Management) 1,67
Streubesitz 57,17
Adresa: Wagistrasse 25, 8952 Schlieren
T: +41-44-733-47-47
F: +41-44-733-47-40
I: http://kurosbio.com
E: [email protected]